| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 7, 2016FORWARD Clinical Study Designed to Confirm the Exceptional Results Achieved in the Evolut R CE Study
DUBLIN - March 7, 2016 - Medtronic plc (NYSE: MDT) today announced the first patients enrolled in the Evolut R FORWARD Clinical Study, a global, multi-center, single-arm, prospective study of up...
-
Mar 7, 2016
DUBLIN - Mar 7, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced it will participate in the Barclays Global Healthcare Conference on...
-
Mar 4, 2016
DUBLIN - Mar 4, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced it will participate in the 36th Annual Cowen & Company Healthcare...
-
Mar 4, 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Mar 3, 2016FDA Approval of Medtronic Specify® SureScan® MRI Surgical Leads Rounds Out Exclusive Portfolio Designed for Access to Full-Body MRI[*]
DUBLIN - March 3, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Specify® SureScan® MRI surgical leads, which are indicated for use as part...
-
Mar 1, 2016
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Mar 1, 2016Revenue of $6.9 Billion Grew 6% on a Comparable, Constant Currency Basis; 61% as Reported
DUBLIN - March 1, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2016, which ended January 29, 2016. Unless otherwise noted, all revenue...
-
Feb 25, 2016- Fourth Quarter 2015 Revenue of $68.1 Million
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 22, 2016
DUBLIN - February 22, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication trial for the CoreValve® Evolut® R System,...
-
Feb 21, 2016Now Offering Both 1.5 and 3 Tesla Indications for MR-Conditional ICMs, Pacemakers, ICDs and CRT-Ds
DUBLIN - February 22, 2016 - Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for the first and only cardiac resynchronization therapy defibrillators...
-
Feb 19, 2016Ranked Second Within Medical Products and Equipment Category
DUBLIN - February 19, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, has been designated as one of the World's Most Admired Companies by FORTUNE...
-
Feb 19, 2016
DUBLIN - February 19, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2016 fourth quarter cash dividend of $0.38 per ordinary share, representing a 25...
-
Feb 19, 2016
DUBLIN - February 19, 2016 - Medtronic plc (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2016 on Tuesday, March 1, 2016. A news release will...
-
Feb 18, 2016SEER Pooled, Patient-Level Analysis of SWIFT PRIME, EXTEND-IA, ESCAPE and REVASCAT Shows Safety and Efficacy of Solitaire Device
DUBLIN - February 18, 2016 - A meta-analysis published online today in Stroke and presented at the International Stroke Conference (ISC) in Los Angeles, Calif., found that the addition of...
-
Feb 17, 2016Approval Expands Population of Individuals Who May Benefit From the Proven Therapy
DUBLIN - February 17, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Medtronic Deep Brain Stimulation (DBS) Therapy for use in people with...
-
Feb 12, 2016The NICE guidance reviewed two sensor-augmented insulin pump therapy systems and recommends the MiniMed® Paradigm Veo(TM) system for managing glucose levels in people with Type 1 diabetes.1
DUBLIN - February 12, 2016 - Today, the United Kingdom's National Institute for Health and Care Excellence (NICE) has issued positive guidance for the use of Medtronic insulin pump systems...
-
Feb 12, 2016
HeartWare International, Inc. (NASDAQ: HTWR) has scheduled a conference call and webcast to discuss its financial results for the three and 12 months ended December 31, 2015, on Thursday, February...
-
Feb 9, 2016Sanford Health in Collaboration with Medtronic Leads Global Efforts to Address Challenging Vascular Condition
DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health...
-
Feb 5, 2016Amplia MRI(TM) and Compia MRI(TM) CRT-Ds, Approved for Patients with Heart Failure, Can Safely Undergo Full Body MRI Scans
DUBLIN - Feb. 5, 2016 - Medtronic plc (NYSE:MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the first and only magnetic resonance imaging (MRI)...
-
Feb 5, 2016iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy
MILAN - February 5, 2016 - A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, demonstrates that patients with type 2...
-
Feb 2, 2016HeartWare Presentation At The Leerink Partners 5th Annual Global Healthcare Conference To Be Webcast
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Feb 1, 2016New Extra-Large Vessel Stent Sizes and Indications in the EU Expand Treatment Options for Patients with Coronary Artery Disease
DUBLIN - February 1, 2016 - Medtronic plc (NYSE: MDT) today announced the recent CE (Conformité Européene) Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES, a next...
-
Feb 1, 2016
DUBLIN - February 1, 2016 - Furthering its commitment to improve outcomes, expand therapy access, and optimize costs and efficiencies in end stage renal disease (ESRD), Medtronic plc (NYSE: MDT)...
-
Jan 30, 2016
NEW DELHI – 30 January 2016 – For the second year in a row, Medtronic hosted the Medical Device Summit in New Delhi on 30th January 2016, bringing together leading national and international...
-
Jan 29, 2016
DUBLIN - January 29, 2016 - Medtronic plc (NYSE: MDT) will present data on the world's smallest pacemaker, the Micra® Transcatheter Pacing System (TPS), at the U.S. Food and Drug Administration...
-
Jan 28, 2016- HeartWare to Add New Board Member -
HeartWare International, Inc. (HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today...
-
Jan 28, 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jan 13, 2016Minimally-Invasive Procedure Brings Relief to Patients Suffering from Painful Spine Tumors
DUBLIN - January 13, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the OsteoCool(TM) RF Ablation System. For...
-
Jan 11, 2016Executing Incremental $5 Billion Share Repurchase
DUBLIN - Jan 11, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today updated its capital allocation plans for the approximately $9.3 billion...
-
Jan 11, 2016New Agreement Will Help Expand Access to Advanced Diabetes Therapies in China
DUBLIN and CHENGDU, China - January 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, has formed a partnership with the Chengdu municipal government to manufacture and...
-
Jan 11, 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jan 11, 2016· Fourth Quarter 2015 Preliminary Revenue Approximately $68 Million
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jan 11, 2016IN.PACT Admiral DEB with 40 Centimeter Catheter Enables Physicians to Maintain Arteriovenous (AV) Access in Patients Undergoing Hemodialysis
DUBLIN - January 11, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today announced that the IN.PACT® Admiral® drug eluting balloon (DEB) (also...
-
Dec 30, 2015-- Company Remains Committed to Value-Enhancing Acquisition of Valtech Cardio, Ltd. --
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Dec 17, 2015
DUBLIN - Dec 17, 2015 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced it will participate in the 34th Annual J.P. Morgan Healthcare...
-
Dec 16, 2015
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Dec 14, 2015Live On. Give On: Medtronic Philanthropy Provides MedTech Patients with $20,000 Grant to Direct to a Charitable Cause of Their Choice
DUBLIN - December 14, 2015 - Medtronic (NYSE: MDT) announced today that 12 people representing 11 countries will be honored with the 2015 Bakken Invitation Award, which recognizes people who have...
-
Dec 14, 2015New facility to manufacture Medtronic's market- leading drug-coated balloons (DCB) technology
DUBLIN- December 14, 2015 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions, today announced a new manufacturing facility in Galway, Ireland that will...
-
Dec 11, 2015
DUBLIN - December 11, 2015 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2016 third quarter cash dividend of $0.38 per ordinary share, representing a 25...
-
Dec 11, 2015Approval adds new implants and new surgical approaches to current spine labeling
DUBLIN - December 11, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of additional spine surgery indications for Infuse® Bone Graft. Upon...
-
Dec 11, 2015
DUBLIN - December 11, 2015 - Medtronic plc (NYSE:MDT), the global leader in medical technology, and Samsung Electronics America, a global leader in consumer electronics and digital health, today...
-
Dec 9, 2015Updated Labeling Allows Greater Patient Access to MRI, a Critical Diagnostic Tool
DUBLIN - December 9, 2015 - Medtronic plc (NYSE: MDT) today announced that systems within its Activa® portfolio of Deep Brain Stimulation (DBS) neurostimulators have received FDA approval for...
-
Dec 8, 2015The Newly Formed U.S. HeartRescue Consortium Will Bring Proven Resuscitation Practices to More States to Improve Sudden Cardiac Arrest Survival Rates
DUBLIN - December 8, 2015 - Medtronic (NYSE: MDT) today announced that the University of Washington and King County (Seattle) Emergency Medical Services will lead the U.S. expansion of the...
-
Dec 3, 2015Revenue of $7.1 Billion Grew 6% on a Comparable, Constant Currency Basis; 62% as Reported
DUBLIN - December 3, 2015 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2016, which ended October 30, 2015. Unless otherwise noted, all...
-
Dec 2, 2015
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Dec 2, 2015New U.S. Distribution Agreement Extends Reach into Primary Care Physician Market
DUBLIN and MELVILLE, N.Y. - December 2, 2015 - Medtronic plc (NYSE:MDT), the global leader in medical technology, has selected Henry Schein Medical, the U.S. Medical business of Henry Schein, Inc....
-
Nov 30, 2015Simplified Report Uses New Algorithms to Streamline Diabetes Data Interpretation for the Health Care Professional
DUBLIN - November 30, 2015 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the availability of a new CareLink® iPro report called Pattern Snapshot for iPro2...
-
Nov 24, 2015
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 20, 2015
DUBLIN - Nov. 20, 2015 - Medtronic plc (NYSE:MDT) has conducted a preliminary review of the United States Department of Treasury's Notice 2015-79, issued on November 19, 2015, which is aimed at...
-
Nov 18, 2015Aircraft's Offering Allows Clinicians a Single, Hybrid Device for All Intubations
DUBLIN - November 18, 2015 - In support of the company's therapy innovation strategy, Medtronic plc (NYSE:MDT) today announced it has acquired Aircraft Medical, a privately-held medical device...
-
Nov 17, 2015MyCareLink Smart(TM) Monitor Conveniently Connects Pacemaker Patients and Doctors System Compatible with Android(TM) and Apple® Smartphones and Tablets
DUBLIN - Nov. 17, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial availability of the MyCareLink Smart(TM) Monitor, the...
-
Nov 17, 2015
DUBLIN and NEW YORK CITY- November 17, 2015 - Selected for nearly one of every two endovascular abdominal aortic aneurysm (AAA) repairs globally, the Endurant® AAA stent graft system from...
-
Nov 16, 2015Medtronic Showcases Aortic Leadership in Innovation with Clinical Release and Pipeline at VEITH 2015New Aortic Data Demonstrates Medtronic's Commitment to Innovation
DUBLIN - November 16, 2015 - Medtronic plc (NYSE: MDT) today announced notable clinical studies and innovative technologies that will be presented at the annual VEITHsymposium, the world's premier...
-
Nov 12, 2015
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 12, 2015
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 9, 2015Data Presented at AHA and Simultaneously Published in the New England Journal of Medicine Demonstrate High Implant Success and Reduced Healthcare Utilization
DUBLIN and ORLANDO - Nov. 9, 2015 - In the largest clinical data presentation ever of transcatheter pacing patients, Medtronic plc (NYSE: MDT) today announced that the Medtronic Micra®...
-
Nov 9, 2015New, Innovative Technology Brings Relief to Patients Suffering with Varicose Veins
DUBLIN - November 9, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. availability of the VenaSeal(TM) closure system, the first and only non-tumescent, non-thermal, non-sclerosant procedure...
-
Nov 6, 2015
DUBLIN - Nov. 6, 2015 - Medtronic plc (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2016 on Thursday, December 3, 2015. A news release will...
-
Nov 6, 2015
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 5, 2015"Further, Together" Showcases the Company's Economic, Social and Environmental Performance in Fiscal Year 2015
DUBLIN - November 5, 2015 - Medtronic plc (NYSE:MDT) announces the release of its 2015 Integrated Performance Report, "Further, Together", which provides a compelling, comprehensive view of how...
-
Nov 5, 2015World's Smallest Pacemaker and Investigational Insulin Pump System Recognized Among the Top 100 Technology Innovations
DUBLIN - November 18, 2015 - Medtronic plc (NYSE: MDT) today announced that its Micra® Transcatheter Pacing System (TPS) and Hybrid Closed Loop system have both earned the 2015 'Best of What's...
-
Nov 3, 2015
HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 2, 2015Health-Economic Analysis Demonstrates Medtronic IN.PACT Admiral Drug-Coated Balloon Is Cost-Effective Compared to Standard PTA; Global Study Data Demonstrates Strong Clinical Outcomes in Patients with In-Stent Restenosis
DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) adds to the robust data for its IN.PACT® Admiral® drug-coated balloon (DCB) with the presentation of both its formal...
-
Nov 2, 2015Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015Meeting Highlights New Two-Year Data with Valiant Thoracic Stent Graft in Type B Aortic Dissection and Nine-Month Comparison Data in Leading Treatments for Peripheral Iliac Artery Disease
DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial...
-
Nov 2, 2015VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon Therapy
DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) announced today the initiation of the REALITY Study (DiRectional AthErectomy + Drug-coAted BaLloon to Treat Long, Calcified...
-
Oct 29, 2015-- Total revenue of $65.2 million reflects completion of enrollment in destination therapy clinical trial and international currency weakness
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Oct 29, 2015Former New York Giant Carl Banks Joins to Support Activities in New York City
DUBLIN - October 29, 2015 - In recognition of World Stroke Day, Medtronic plc (NYSE: MDT) and the World Stroke Organization are joining together for the second year to raise awareness of stroke,...
-
Oct 28, 2015Medtronic Pioneered the First Stent Retriever in 2007 with the Introduction of the SolitaireTM Stent Retriever Device
DUBLIN - October 28, 2015 - The Cleveland Clinic has named stent retriever technology, which includes Medtronic plc's (NYSE: MDT) SolitaireTM stent retriever device, to a list of the top medical...
-
Oct 28, 2015
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Oct 28, 2015New Data Presented at ANESTHESIOLOGY® 2015 Demonstrates the Value of Integrated Pulmonary IndexTM and MicrostreamTM Capnography
SAN DIEGO - October 28, 2015 - Medtronic plc (NYSE: MDT) today announced findings from two clinical studies, the first validating the clinical utility of the Integrated Pulmonary Index(TM) (IPI)...
-
Oct 21, 2015Diagnosing AF with Visia AF(TM) and Visia AF MRI(TM) SureScan® ICDs Enables Physicians to Manage Patients at Increased Risk for Stroke and Heart Failure
DUBLIN - October 21, 2015 - Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for the Visia AF(TM) and Visia AF MRI(TM) SureScan® single-chamber...
-
Oct 21, 2015Opening in 2016, the Museum Will Explore the African American Experience and How It Helped Shape American History and Culture.
DUBLIN - Oct. 21, 2015 - Medtronic (NYSE: MDT) today announced that it will become a founding donor to the Smithsonian's National Museum of African American History and Culture, committing $2...
-
Oct 20, 2015
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended September 30, 2015, at 8:00 a.m. U.S. ET on Thursday,...
-
Oct 19, 2015Pillsbury United Communities, Regions Hospital Foundation, HealthFinders Collaborative Will Implement "HealthRise" in Minnesota, One of Four Projects in the World.
MINNEAPOLIS - October 19, 2015 - Medtronic (NYSE: MDT) today announced that Pillsbury United Communities, Regions Hospital Foundation and the HealthFinders Collaborative have been selected by...
-
Oct 15, 2015
DUBLIN and CHICAGO - October 15, 2015 - Medtronic plc (NYSE: MDT) today announced favorable seven-year data maintaining improved clinical outcomes and patient satisfaction for the Prestige LP(TM)...
-
Oct 14, 2015Presented at TCT and Published in JACC, Two-Year Outcomes Reinforce IN.PACT Admiral's Durability, Consistency and Safety as a Best-in-Class Treatment Option for PAD
DUBLIN and SAN FRANCISCO - October 14, 2015 - Medtronic plc (NYSE: MDT) announced today that new two-year clinical data from the pivotal IN.PACT SFA Trial revealed that the IN.PACT® Admiral®...
-
Oct 14, 2015New Data Released at TCT 2015 Affirms Strong Performance of Recapturable and Repositionable Heart Valve Yielding Low Rates of Mortality and Stroke with Excellent Hemodynamics
DUBLIN and SAN FRANCISCO - October 14, 2015 - Medtronic plc (NYSE: MDT) announced new one-year data showing transcatheter aortic valve replacement (TAVR) with the CoreValve® Evolut® R System-the...
-
Oct 13, 2015New Data Show Low Mortality and Improved Quality of Life for Patients with Failed Surgical Aortic Valves, End-Stage Renal Disease and Low Gradient Aortic Stenosis
DUBLIN and SAN FRANCISCO - October 13, 2015 - Medtronic plc (NYSE: MDT) today unveiled new clinical data that showed positive clinical outcomes at one year for the CoreValve System in new patient...
-
Sep 14, 2015Evera MRI ICD System Approved for Use During Full Body MRI Scans for Patients at Risk of Sudden Cardiac Arrest
DUBLIN - Sept. 14, 2015 - Medtronic plc (NYSE: MDT) today announced that it has received the first U.S. Food and Drug Administration (FDA) approval for an implantable cardioverter defibrillator...
-
May 18, 2015Positive Results from Two Studies Featured at Heart Rhythm Society 36th Annual Scientific Sessions
DUBLIN and BOSTON - MAY 18, 2015 -Medtronic plc (NYSE: MDT) today announced study results demonstrating that its quadripolar cardiac resynchronization therapy (CRT) system gives physicians more...
-
May 12, 2015Third-Generation Cryoballoon Designed to Allow Enhanced Positioning and Help Improve Capture of Real-Time Data with Achieve® Mapping Catheter
DUBLIN - May 12, 2015 - Medtronic plc (NYSE: MDT) today announced the Arctic Front Advance® ST Cryoablation Catheter has received U.S. Food and Drug Administration (FDA) approval for the...
-
May 7, 2015RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting
DUBLIN – May 7, 2015 – Medtronic plc (NYSE: MDT) today announced the first inoffice implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study....
-
Feb 19, 2015CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Upper Leg
DUBLIN - Feb. 19, 2015 - Medtronic plc (NYSE: MDT) announced today that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company's...
-
Feb 11, 2015Findings Reinforce Patient Benefit of Reveal LINQ in Real-World Setting
DUBLIN and NASHVILLE – Feb. 11, 2015 – Medtronic plc (NYSE: MDT), today announced the results of a new “real-world” study of patients who have had a cryptogenic stroke (stroke of unknown...
-
Feb 4, 2015First Uses of New Medical Device Following FDA Approval Take Place at Hospitals Nationwide
DUBLIN – Feb. 4, 2015 – U.S. hospitals this week began using a new medical device from Medtronic plc (NYSE: MDT) called the IN.PACT Admiral drug-coated balloon (DCB) to treat patients with...
-
Jan 29, 2015New Results from PainFree SST, Shock-Less Studies, Involving Nearly 7,000 Patients, Published in HeartRhythm
DUBLIN and MINNEAPOLIS - Jan. 29, 2015 - Medtronic plc (NYSE: MDT) today announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm. The data...
-
Jan 5, 2015Pivotal Study Shows New Medical Device Provides Exceptional Clinical Outcomes and Reduces Need for Costly Repeat Procedures
MINNEAPOLIS -- Jan. 5, 2015 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's IN.PACT Admiral drug-coated balloon (DCB) for...
-
Dec 30, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 3, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 30, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 30, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 28, 2014Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and Transform Outcomes for Hospitals, Surgeons, and Patients
DUBLIN - December 19, 2018 - Medtronic plc (NYSE:MDT) today announced it has completed the acquisition of Israel-based Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ). Under the terms of the...
-
Dec 23, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 23, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 21, 2014Results of IN.PACT SFA Trial Published in Circulation
MINNEAPOLIS -- Dec. 22, 2014 -- The results of a landmark study published this month in Circulation, the world's leading cardiovascular journal, indicate that a novel medical device from...
-
Dec 20, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 2, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 19, 2014Next-Generation System with Breakthrough Advancement in Closed-Loop Technology Furthers Global Innovation
MINNEAPOLIS - December 19, 2014 - Medtronic, Inc. (NYSE:MDT) today announced it has completed global user evaluations of a next generation system that uses the new pump platform and represents a...
-
Dec 17, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 17, 2014-- In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute...
-
Dec 17, 2014Innovative design of wireless, vitamin-sized capsule recognized for its profound impact on improving the standard-of-care for small bowel examinations
NEW YORK--(BUSINESS WIRE)--Dec. 17, 2014-- PillCam® SB, Covidien’s wireless capsule endoscope, is now featured in the exhibit, “Tools: Extending Our Reach” at New York’s Cooper Hewitt...
-
Dec 16, 2014Medtronic Philanthropy Grants Support Local Organizations Committed to Expanding Access to Healthcare for the Underserved
MINNEAPOLIS - December 16, 2014 - Rocky Mountain Youth Clinics, Roundup River Ranch and the Parkinson Association of the Rockies each received a two-year $50,000 Health Access Grant from Medtronic...
-
Dec 15, 2014NovaShield(TM) Offers Convenient Tool to Control Minimal Bleeding, Prevent Adhesions, and Provide Antibacterial Effectiveness after FESS*
MINNEAPOLIS - December 15, 2014 - Medtronic (NYSE: MDT) today announced the launch of the NovaShield(TM) Injectable Nasal Packing and Stent for functional endoscopic sinus surgery (FESS),...
-
Dec 11, 2014Additional Attain Performa® Quadripolar Leads Provide Physicians with More Options to Optimize Delivery of Proven Heart Failure Treatment
MINNEAPOLIS - Dec. 11, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa® left...
-
Dec 11, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 11, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...